Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: A new or a complementary diagnostic score?

Digestive and Liver Disease

Volumn 42, Issue 11, 2010, Pages 807-812

  Gatselis, Nikolaos K ^a   Zachou, Kalliopi ^a,b   Papamichalis, Panagiotis ^a   Koukoulis, George K ^a   Gabeta, Stella ^a,b   Dalekos, George N ^a,b   Rigopoulou, Eirini I ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

Alcoholic liver disease; Autoimmune hepatitis; International Autoimmune Hepatitis Group (IAIHG); Non alcoholic steatohepatitis; Overalp syndromes; Primary biliary cirrhosis; Primary sclerosing cholangiitis; Viral hepatitis

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; ALCOHOLIC FATTY LIVER; ARTICLE; AUTOIMMUNE HEPATITIS; CHOLESTATIC HEPATITIS; CONTROLLED STUDY; DELTA AGENT HEPATITIS; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AUTOANTIBODIES; BIOPSY; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DISSENT AND DISPUTES; FEMALE; GREECE; GUIDELINE ADHERENCE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77957274378     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.03.005     Document Type: Article

References (38)

1. Boberg K.M., Aadland E., Jahnsen J., et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998, 33:99-103.
2. Zachou K., Rigopoulou E., Dalekos G.N. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis 2004, 1:2.
3. Dalekos G.N., Zachou K., Liaskos C., et al. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur J Intern Med 2002, 13:293-303.
4. Czaja A.J. Autoimmune liver disease. Curr Opin Gastroenterol 2009, 25:215-222.
5. Czaja A.J. Current and future treatments of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2009, 3:269-291.
6. Czaja A.J. Autoimmune hepatitis. Part B: diagnosis. Expert Rev Gastroenterol Hepatol 2007, 1:129-143.
7. Feld J.J., Dinh H., Arenovich T., et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005, 42:53-62.
8. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938.
9. Hennes E.M., Zeniya M., Czaja A.J., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176.
10. Czaja A.J. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008, 48:1540-1548.
11. Yeoman A.D., Westbrook R.H., Al-Chalabi T., et al. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology 2009, 50:538-545.
12. Muratori P., Granito A., Pappas G., et al. Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. Hepatology 2009, 49:1782-1783.
13. Papamichalis P.A., Zachou K., Koukoulis G.K., et al. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis 2007, 4:3.
14. Wiegard C., Schramm C., Lohse A.W. Scoring systems for the diagnosis of autoimmune hepatitis: past, present and future. Semin Liver Dis 2009, 29:254-261.
15. Beuers U. Hepatic overlap syndromes. J Hepatol 2005, 42(Suppl.):S93-S99.
16. Liaskos C., Rigopoulou E., Zachou K., et al. Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J Autoimmun 2005, 24:251-260.
17. Satra M., Dalekos G.N., Kollia P., et al. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections. J Viral Hepat 2005, 12:488-493.
18. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 2003, 38:533-540.
19. Tsikrikoni A., Kyriakou D.S., Rigopoulou E.I., et al. Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 2005, 42:393-399.
20. Zachou K., Liaskos C., Rigopoulou E., et al. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol 2006, 119:203-212.
21. Poupon R., Chazouilleres O., Poupon R.E. Chronic cholestatic diseases. J Hepatol 2000, 32:129-140.
22. Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37:1202-1219.
23. Zachou K., Yurdaydin C., Drebber U., et al. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int 2010, 30:430-437.
24. Chazouilleres O. Diagnosis of primary sclerosing cholangitis-autoimmune hepatitis overlap syndrome: to score or not to score?. J Hepatol 2000, 33:661-663.
25. Chazouilleres O., Wendum D., Serfaty L., et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998, 28:296-301.
26. Dalekos G.N., Makri E., Loges S., et al. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece. Eur J Gastroenterol Hepatol 2002, 14:35-42.
27. Dalekos G.N., Wedemeyer H., Obermayer-Straub P., et al. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment. J Hepatol 1999, 30:366-375.
28. Vergani D., Alvarez F., Bianchi F.B., et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004, 41:677-683.
29. Yatsuji S., Hashimoto E., Kaneda H., et al. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?. J Gastroenterol 2005, 40:1130-1138.
30. Muratori L., Lenzi M., Cataleta M., et al. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol 1994, 21:199-203.
31. Zervou E.K., Dalekos G.N., Boumba D.S., et al. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 2001, 41:652-658.
32. Panagopoulos P., Economou A., Kasimi A., et al. Prevalence of hepatitis B and C in the maternity department of a Greek district hospital. J Matern Fetal Neonatal Med 2004, 16:106-110.
33. Dalekos G.N., Zervou E., Karabini F., et al. Prevalence of viral markers among refugees from southern Albania: increased incidence of infection with hepatitis A, B and D viruses. Eur J Gastroenterol Hepatol 1995, 7:553-558.
34. Gatselis N.K., Rigopoulou E., Stefos A., et al. Risk factors associated with HCV infection in semi-rural areas of central Greece. Eur J Intern Med 2007, 18:48-55.
35. Stefos A., Gatselis N., Zachou K., et al. Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece. Eur J Intern Med 2009, 20:35-43.
36. Zervou E.K., Gatselis N.K., Xanthi E., et al. Intrafamilial spread of hepatitis B virus infection in Greece. Eur J Gastroenterol Hepatol 2005, 17:911-915.
37. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 2006, 354:54-66.
38. Rigopoulou E.I., Dalekos G.N. Autoimmune hepatitis: of host and pathogen. Hepatology 2008, 47:2147-2148.